ibutilide has been researched along with Torsade de Pointes in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 14 (66.67) | 29.6817 |
| 2010's | 6 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Le, DD; Levis, JT; Lugovskaya, N; Vinson, DR | 1 |
| Havakuk, O; Viskin, S | 1 |
| Reiffel, JA | 1 |
| Antonatos, D; Babalis, D; Christou, A; Kafkas, N; Katsanos, S; Nikolaou, N; Patsilinakos, S; Spanodimos, S | 1 |
| Antoons, G; Beekman, JD; Boulaksil, M; de Bakker, JM; de Boer, TP; Houtman, MJ; Jungschleger, JG; Maessen, JG; van der Heyden, MA; van der Hulst, FF; van Rijen, HV; van Veen, TA; Vos, MA; Wilders, R | 1 |
| Crijns, HJ; Vos, MA | 1 |
| Caron, MF; Coleman, CI; Kalus, JS; Kluger, J; White, CM | 1 |
| Paulussen, AD; Vos, MA | 1 |
| Gowda, RM; Khan, IA; Punukollu, G; Sacchi, TJ; Vasavada, BC; Wilbur, SL | 1 |
| Brendorp, B; Elming, H; Køber, L; Pedersen, OD; Pehrson, S; Torp-Petersen, C | 1 |
| Kluger, J; Shah, SA; White, CM | 1 |
| Brunden, MN; Buchanan, LV; Gibson, JK; Kabell, G | 1 |
| Chang, MS; Chen, SA; Chen, YJ; Ding, YA; Hsieh, MH; Lee, SH | 1 |
| Chow, MS; Dunn, AB; Kluger, J; Reddy, P; White, CM | 1 |
| Abrahamsson, C; Amos, GJ; Carlsson, L; Duker, G; Hondeghem, L; Palmer, M | 1 |
| Chatterjee, K; Cheng, J; Glatter, K; Kayser, S; Modin, G; Scheinman, MM; Yang, Y | 1 |
| Kilborn, MJ; Liu, XK; Pezzullo, JC; Rodriguez, I; Woosley, RL | 1 |
| Carlsson, L; Johansson, M | 1 |
| Amlie, JP; Harg, P; Madsen, S | 1 |
5 review(s) available for ibutilide and Torsade de Pointes
| Article | Year |
|---|---|
Myocardial repolarization and drugs. Impossibility to predict the dominance of anti-arrhythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Disease Models, Animal; Humans; Phenethylamines; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2001 |
Genetic basis of drug-induced arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cytochrome P-450 Enzyme System; Dogs; Electrocardiography; Long QT Syndrome; Mutation; Sulfonamides; Torsades de Pointes | 2004 |
Female preponderance in ibutilide-induced torsade de pointes.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Incidence; Male; Sex Distribution; Sulfonamides; Torsades de Pointes | 2004 |
A benefit-risk assessment of class III antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Combined Modality Therapy; Defibrillators, Implantable; Dronedarone; Heart Conduction System; Humans; Hydantoins; Imidazolidines; Ion Transport; Life Tables; Membrane Potentials; Meta-Analysis as Topic; Phenethylamines; Piperazines; Risk Assessment; Sotalol; Sulfonamides; Survival Analysis; Torsades de Pointes; Treatment Outcome | 2004 |
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Drug Therapy, Combination; Electrocardiography; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Humans; Sotalol; Sulfonamides; Torsades de Pointes | 2007 |
2 trial(s) available for ibutilide and Torsade de Pointes
| Article | Year |
|---|---|
Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Drug Therapy, Combination; Female; Humans; Magnesium Sulfate; Male; Middle Aged; Sulfonamides; Torsades de Pointes; Treatment Outcome | 2010 |
Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Female; Humans; Magnesium; Male; Middle Aged; Monte Carlo Method; Sulfonamides; Torsades de Pointes; United States | 2004 |
14 other study(ies) available for ibutilide and Torsade de Pointes
| Article | Year |
|---|---|
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
ECG Diagnosis: Ibutilide-induced Torsade de Pointes.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Humans; Male; Middle Aged; Sulfonamides; Torsades de Pointes | 2019 |
Reply: Long-QT Syndrome, Brugada Syndrome, and Catecholaminergic Polymorphic Ventricular Tachycardia: A Tale of 3 Diseases : Ibutilide as a Torsade de Pointes Stress Test.
Topics: Brugada Syndrome; Electrocardiography; Exercise Test; Humans; Long QT Syndrome; Sulfonamides; Tachycardia, Ventricular; Torsades de Pointes | 2016 |
Ibutilide as a Torsade de Pointes Stress Test.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Exercise Test; Humans; Sulfonamides; Torsades de Pointes | 2016 |
Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity.
Topics: Animals; Anti-Arrhythmia Agents; Atrioventricular Block; Collagen; Connexin 43; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Heart Ventricles; Hypertrophy; Refractory Period, Electrophysiological; Sodium Channels; Sulfonamides; Torsades de Pointes; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2011 |
Ibutilide (Corvert): suspected association with torsades de pointes.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Fatal Outcome; Humans; Male; Middle Aged; Sulfonamides; Torsades de Pointes | 2004 |
Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Heart Conduction System; Heart Rate; Male; Methoxamine; Phenethylamines; Piperidines; Pyridines; Quaternary Ammonium Compounds; Rabbits; Software; Sotalol; Sulfonamides; Torsades de Pointes | 1993 |
Proarrhythmic effects of ibutilide in a canine model of pacing induced cardiomyopathy.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiomyopathies; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Heart Rate; Heart Ventricles; Hemodynamics; Male; Sulfonamides; Torsades de Pointes | 2000 |
Efficacy and cost analysis of ibutilide.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Costs and Cost Analysis; Electric Countershock; Female; Humans; Male; Medical Records; Sulfonamides; Torsades de Pointes | 2000 |
Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
Topics: Action Potentials; Alkanes; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Calcium Channels, L-Type; Heart Ventricles; In Vitro Techniques; Inhibitory Concentration 50; Male; Models, Animal; Patch-Clamp Techniques; Perfusion; Potassium Channels; Propanolamines; Purkinje Fibers; Rabbits; Sulfonamides; Torsades de Pointes | 2001 |
Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Sulfonamides; Torsades de Pointes | 2001 |
Drug-induced QT prolongation in women during the menstrual cycle.
Topics: Adult; Analysis of Variance; Anti-Arrhythmia Agents; Electrocardiography; Estradiol; Female; Heart Rate; Humans; Male; Menstrual Cycle; Progesterone; Risk Factors; Sex Factors; Sulfonamides; Testosterone; Torsades de Pointes | 2001 |
Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
Topics: Age Factors; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Female; Long QT Syndrome; Male; Rabbits; Sex Characteristics; Sulfonamides; Torsades de Pointes | 2001 |
[Severe ibutilide-induced arrhythmia in patients with heart failure].
Topics: Aged; Anti-Arrhythmia Agents; Contraindications; Drug Therapy, Combination; Fatal Outcome; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsades de Pointes | 2001 |